Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018 Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018
$2,500 | June 2018 GlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018" provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Systemic Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018 Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018
$2,500 | June 2018 GlobalData's clinical trial report, “Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018" provides an overview of Proliferative Diabetic Retinopathy (PDR) clinical trials scenario. This report provides top line data relating to the clinical trials on Proliferative Diabetic Retinopathy (PDR). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cardiometabolic Disease Global Clinical Trials Review, H2, 2018 Cardiometabolic Disease Global Clinical Trials Review, H2, 2018
$2,500 | December 2018 GlobalData's clinical trial report, “Cardiometabolic Disease Global Clinical Trials Review, H2, 2018" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiometabolic Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Digital Landscape: Type 2 Diabetes Digital Landscape: Type 2 Diabetes
$6,000 | August 2018 The Digital Landscape Type 2 Diabetes report analyzes digital activities undertaken by Pharma in support of therapies for Type 2 Diabetes (T2D).
-
Product Insights
Osteopenia Global Clinical Trials Review, H1, 2018 Osteopenia Global Clinical Trials Review, H1, 2018
$2,500 | April 2018 GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H1, 2018" provides an overview of Osteopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Osteopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Abdominal Obesity Global Clinical Trials Review, H2, 2018 Abdominal Obesity Global Clinical Trials Review, H2, 2018
$2,500 | October 2018 GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H2, 2018" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Obesity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Obesity: Competitive Landscape to 2026 Obesity: Competitive Landscape to 2026
$3,495 | October 2018 Obesity is a preventable chronic condition, defined as abnormal or excessive fat accumulation characterized by raised body mass index (BMI ≥30), which is a major risk factor for chronic diseases such as cardiovascular diseases (CVD), diabetes, musculoskeletal disorders, and several major cancers. This report provides an assessment of the pipeline, clinical, and commercial landscape of Obesity. Overall, GlobalData expects that the approval of new long-acting GLP-1R and dual GLP-1R/GCGR agonists, and a novel appetite reducing drug will drive Obesity market...
-
Product Insights
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018
$2,500 | October 2018 GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018 Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018
$2,500 | September 2018 GlobalData's clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Tumor Lysis Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Tumor Lysis Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018 Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018
$2,500 | September 2018 GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018" provides an overview of Type 1 Diabetes (Juvenile Diabetes) clinical trials scenario. This report provides top line data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.